These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Marked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking dofetilide for atrial fibrillation: a cautionary tale. Nagra BS; Ledley GS; Kantharia BK J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):191-5. PubMed ID: 16211208 [TBL] [Abstract][Full Text] [Related]
9. Dofetilide-induced long QT and torsades de pointes. Aktas MK; Shah AH; Akiyama T Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):197-202. PubMed ID: 17617063 [TBL] [Abstract][Full Text] [Related]
10. The role of amiodarone in recent-onset atrial fibrillation after ibutilide has failed to restore sinus rhythm. Sideris S; Bonios M; Melexopoulou C; Exarchos P; Tsatiris K; Kogias J Cardiology; 2007; 107(4):399-401. PubMed ID: 17284902 [TBL] [Abstract][Full Text] [Related]
11. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome. Johansson M; Carlsson L J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331 [TBL] [Abstract][Full Text] [Related]
12. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome. Wegener FT; Ehrlich JR; Hohnloser SH Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559 [No Abstract] [Full Text] [Related]
13. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone. Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686 [TBL] [Abstract][Full Text] [Related]
14. ECG Diagnosis: Ibutilide-induced Torsade de Pointes. Le DD; Levis JT; Lugovskaya N; Vinson DR Perm J; 2019; 23():. PubMed ID: 30939273 [No Abstract] [Full Text] [Related]
15. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes. Shah SA; Kluger J; White CM Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and cost analysis of ibutilide. Dunn AB; White CM; Reddy P; Chow MS; Kluger J Ann Pharmacother; 2000 Nov; 34(11):1233-7. PubMed ID: 11098333 [TBL] [Abstract][Full Text] [Related]
17. Dofetilide for atrial fibrillation. Med Lett Drugs Ther; 2000 May; 42(1078):41-2. PubMed ID: 10847114 [No Abstract] [Full Text] [Related]
18. Torsade de pointes induced by short-term oral amiodarone therapy. Lim HE; Pak HN; Ahn JC; Song WH; Kim YH Europace; 2006 Dec; 8(12):1051-3. PubMed ID: 17148550 [TBL] [Abstract][Full Text] [Related]
19. Sustained torsade de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease. D'Aloia A; Faggiano P; Brentana L; Boldini A; Pedrinazzi C; Procopio R; Dei Cas L Int J Cardiol; 2005 Dec; 105(3):337-9. PubMed ID: 15985302 [TBL] [Abstract][Full Text] [Related]
20. TORSADES DE POINTES IN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION TREATED BY SHORT-TERM PARENTERAL AMIODARONE THERAPY. Lakušić N; Slivnjak V; Ciglenečki N; Cerovec D Acta Clin Croat; 2019 Dec; 58(4):751-756. PubMed ID: 32665746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]